|
|
 |
|
- Sven Andréasson, MBA, Chairman of the Board,
CEO BetaCell, former CEO Active Biotech, former Pharmacia.
- Philippe Archinard, Ph.D, MBA,
CEO Transgène, former CEO Innogenetics, former BioMérieux.
- Marc Beer, MBA,
CEO Aegerion Pharmaceuticals, former CEO Viacell, former Genzyme VP Global Marketing, former Abbott Laboratories.
- Lennart Bruce, Ph.D.,
CEO Viken Pharma, former BioVitrum Senior VP BD, former Pharmacia.
- Dr Alain Munoz, M.D.,
AGF Private Equity representative, former Fournier VP R&D and BD, former Sanofi.
- Franck Lescure, Ph.D, MBA,
Auriga Partners partner, former Genset, former Air Liquide.
- Glenn Richard, MBA,
AXA Private Equity Senior Investment Manager.
|
|
|
|
